Opiniyum

Pre-launch terms, disclosure & refunds

Required disclosure (British Columbia, Canada)

  • Supplier: Opiniyum, a product of CuprBot Labs Inc., British Columbia, Canada — [email protected]
  • What you are buying (Reserve the rate, CAD $15 once): a refundable founding reservation. It locks the founder rate of CAD $15/month (public price CAD $29/month) for as long as your subscription stays active, and the CAD $15 is credited to your first month when access begins.
  • What you are buying (Founder cohort, CAD $99 once, 50 seats): everything in Reserve the rate, plus your first year of Opiniyum included (12 months at the founder rate, a CAD $180 value), a roadmap vote, founder-only previews and early builds, feature-request priority, and your name in the credits. After the first year the subscription continues at the locked CAD $15/month while active.
  • Estimated delivery: product access for the founding cohort is targeted for early October 2026.
  • Launch guarantee: if your access has not started by November 1, 2026, email [email protected] and your payment is refunded in full to the original payment method.
  • Cancellation & refunds: any time before your access starts, email [email protected] saying you want your money back and it is refunded in full, no questions asked. After access starts, the payment has been applied to your subscription as described above.

The founder rate

The CAD $15/month founder rate is locked for as long as your subscription remains active. If you cancel after activation, the founder rate is not recoverable; rejoining is at the public price.

Founder builder seats

There are 50 founder builder seats. Once they are taken, the Founder cohort option is no longer offered; Reserve the rate remains available and still locks the founder rate. Founder perks (roadmap vote, previews, request priority, credits) are delivered inside the product and by email; none require a call or meeting.

Not medical advice

Opiniyum is a learning and lifestyle tool. It does not diagnose, prevent, or manage any medical condition, and it is not a substitute for professional advice.